// App-Quantinova.ai

P5-03-06 : Clinical value of Zr-trastuzumab PET in HER2-positive breast cancer patients with a clinical dilemma

Researchers

Presenter

  • CP Schröder

Principal Investigators

  • F Bensch

  • AH Brouwers

  • MN Lub-de Hooge

  • JR de Jong

  • B van der Vegt

  • S Sleijfer

  • EG de Vries

Medical Centers

  • Erasmus Medical Center Cancer Institute, Rotterdam, Netherlands

  • Universitair Medisch Centrum Groningen, Groningen, Netherlands

Locations

  • Netherlands

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Breast cancer

  • Brain metastasis

  • Solid malignancies

Biomarkers

  • 18F-fluorodeoxyglucose

  • Circulating tumor cells

  • Human epidermal growth factor receptor 2

Drug/Treatment

  • Trastuzumab

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved